Patient-reported fatigue and its impact on patients with systemic lupus erythematosus

Lupus

Volumn 23, Issue 2, 2014, Pages 124-132

  Sterling, K L ^a   Gallop, K ^b   Swinburn, P ^a   Flood, E ^a   French, A ^a   Sawah, S Al ^a   Iikuni, N ^a   Naegeli, A N ^a   Nixon, A ^b  

^a ELI LILLY AND COMPANY   (United States)

^b ICON PLC   (United Kingdom)

Author keywords

fatigue; HrQoL; lupus; PRO; SLE; tiredness

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CLINICAL ARTICLE; CLINICAL RESEARCH; CLINICAL STUDY; COGNITION; DAILY LIFE ACTIVITY; DEMOGRAPHY; DISEASE DURATION; EMOTION; FATIGUE; FEMALE; HUMAN; LEISURE; MALE; PRIORITY JOURNAL; PURPOSIVE SAMPLE; QUALITATIVE RESEARCH; QUALITY OF LIFE; SEMI STRUCTURED INTERVIEW; SOCIAL BEHAVIOR; SYSTEMIC LUPUS ERYTHEMATOSUS; THEMATIC ANALYSIS; UNITED STATES; WORK;

FATIGUE; HRQOL; LUPUS; PRO; SLE; TIREDNESS;

ACTIVITIES OF DAILY LIVING; ADULT; COGNITION; CROSS-SECTIONAL STUDIES; EMOTIONS; EMPLOYMENT; FATIGUE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SOCIAL BEHAVIOR;

EID: 84892592634     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313511554     Document Type: Article

References (57)

1. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
2. Bertsias G, Ioannidis JP, Boletis J, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis. 2008 ; 67: 195-205
3. Tench CM, McCurdie I, White PD, D'Cruz DP. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford). 2000 ; 39: 1249-1254
4. Cleanthous S, Tyagi M, Isenberg DA, Newman SP. What do we know about self-reported fatigue in systemic lupus erythematosus?. Lupus. 2012 ; 21: 465-476
5. Ahn GE, Ramsey-Goldman R. Fatigue in systemic lupus erythematosus. Int J Clin Rheumtol. 2012 ; 7: 217-227
6. Ramsey-Goldman R, Rothrock N. Fatigue in systemic lupus erythematosus and rheumatoid arthritis. PM R. 2010 ; 2: 384-392
7. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011 ; 365: 2110-2121
8. Pons-Estel GJ, Alarcón GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010 ; 39: 257-268
9. Da Costa D, Dritsa M, Bernatsky S, et al. Dimensions of fatigue in systemic lupus erythematosus: Relationship to disease status and behavioral and psychosocial factors. J Rheumatol. 2006 ; 33: 1282-1288
10. Piper BF Pathophysiological phenomena in nursing, human response to illness. Carrieri V Lindsey AM West CM, ed. Philadelphia: Saunders ; 1993 :
11. Balsamo S, Santos-Neto LD. Fatigue in systemic lupus erythematosus: An association with reduced physical fitness. Autoimmun Rev. 2011 ; 10: 514-518
12. Measurement of fatigue in systemic lupus erythematosus: A systematic review. Arthritis Rheum. 2007 ; 57: 1348-1357
13. Costenbader KH, Fidias P, Gilman MD, Qureshi A, Tambouret RH. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-2006. A 43-year-old woman with painful nodules on the fingertips, shortness of breath, and fatigue. N Engl J Med. 2006 ; 355: 1263-1272
14. Wang M, Gladman DD, Ibañez D, Urowitz. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012 ; 64: 833-837
15. Somers TJ, Kurakula PC, Criscione-Schreiber L, Keefe FJ, Clowse ME. Self-efficacy and pain catastrophizing in systemic lupus erythematosus: Relationship to pain, stiffness, fatigue, and psychological distress. Arthritis Care Res (Hoboken). 2012 ; 64: 1334-1340
16. Burgos PI, Alarcón GS, McGwin G, Crews KQ, Reveille JD, Vilá LM. Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII. Arthritis Rheum. 2009 ; 61: 1179-1186
17. Kirwan J, Heiberg T, Hewlett S, et al. Outcomes from the Patient Perspective Workshop at OMERACT 6. J Rheumatol. 2003 ; 30: 868-872
18. Yen JC, Neville C, Fortin PR. Discordance between patients and their physicians in the assessment of lupus disease activity: Relevance for clinical trials. Lupus. 1999 ; 8: 660-670
19. Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Outcome measures to be used in clinical trials in systemic lupus erythematosus. J Rheumatol. 1999 ; 26: 490-497
20. Food and Drug Administration: Guidance for Industry. Systemic Lupus Erythematosus - Developing Medical Products for Treatment. June 2010. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm072063.pdf (accessed 25.10.2013).
21. Robinson D, Aguilar D, Schoenwetter M, et al. Impact of systemic lupus erythematosus on health, family, and work: The patient perspective. Arthritis Care Res (Hoboken). 2010 ; 62: 266-273
22. Beckerman NL. Living with lupus: A qualitative report. Soc Work Health Care. 2011 ; 50: 330-343
23. Hassett AL, Li T, Radvanski DC, et al. The assessment of health-related family role functioning in systemic lupus erythematosus: Preliminary validation of the SLE-FAMILY. Arthritis Care Res (Hoboken). 2012 ; 64: 1341-1348
24. Mattsson M, Möller B, Stamm T, Gard G, Boström C. Uncertainty and opportunities in patients with established systemic lupus erythematosus: A qualitative study. Musculoskeletal Care. 2012 ; 10: 1-12
25. McElhone K, Abbott J, Gray J, Williams A, Teh LS. Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: A qualitative study. Lupus. 2010 ; 19: 1640-1647
26. Pettersson S, Möller S, Svenungsson E, Gunnarsson I, Welin Henriksson E. Women's experience of SLE-related fatigue: A focus group interview study. Rheumatology (Oxford). 2010 ; 49: 1935-1942
27. Gallop K, Nixon A, Swinburn P, Sterling KL, Naegeli AN, Silk ME. Development of a conceptual model of health-related quality of life for systemic lupus erythematosus (SLE) from the patient's perspective. Lupus. 2012 ; 21: 934-943
28. Critical Appraisal Skills Programme. Making sense of evidence about clinical effectiveness, http://www.casp-uk.net/wp-content/uploads/2011/11/CASP- Qualitative-Appraisal-Checklist-14oct10.pdf (2010, accessed 14 October 2010).
29. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
30. D'Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet. 2007 ; 369: 587-596
31. McElhone K, Abbott J, Teh LS. A review of health related quality of life in systemic lupus erythematosus. Lupus. 2006 ; 15: 633-643
32. Maeshima E, Maeshima S, Mizobata R, et al. Life-style activities in systemic lupus erythematosus. Clin Exp Rheumatol. 2007 ; 25: 189-194
33. Jump RL, Robinson ME, Armstrong AE, Barnes EV, Kilbourn KM, Richards HB. Fatigue in systemic lupus erythematosus: Contributions of disease activity, pain, depression, and perceived social support. J Rheumatol. 2005 ; 32: 1699-1705
34. Yee SE, McElhone K, Teh LS, Gordon C. Assessment of disease activity and quality of life in systemic lupus erythematosus - New aspects. Best Pract Res Clin Rheumatol. 2009 ; 23: 457-467
35. Stamm TA, Bauernfeind B, Coenen M, et al. Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status. Arthritis Rheum. 2007 ; 57: 1287-1295
36. Alarcón GS, McGwin G, Uribe A, et al. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum. 2004 ; 51: 465-474
37. Archenholtz B, Burckhardt CS, Segesten K. Quality of life of women with systemic lupus erythematosus or rheumatoid arthritis: Domains of importance and dissatisfaction. Qual Life Res. 1999 ; 8: 411-416
38. Bruce IN, Mak VC, Hallett DC, Gladman DD, Urowitz MB. Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis. 1999 ; 58: 379-381
39. Doward LC, McKenna SP, Whalley D, et al. The development of the L-QoL: A quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis. 2009 ; 68: 196-200
40. Goodman D, Morrissey S, Graham D, Bossingham D. Illness representations of systemic lupus erythematosus. Qual Health Res. 2005 ; 15: 606-619
41. Lash AA. Quality of life in systemic lupus erythematosus. Appl Nurs Res. 1998 ; 11: 130-137
42. Lau A, Feng PH. Two perspectives on lupus: Patient and doctor. Lupus. 2010 ; 19: 1362-1364
43. Panopalis P, Clarke AE. Quality of life in systemic lupus erythematosus. Clin Dev Immunol. 2006 ; 13: 321-324
44. Seawell AH, Danoff-Burg S. Psychosocial research on systemic lupus erythematosus: A literature review. Lupus. 2004 ; 13: 891-899
45. Sweet JJ, Doninger NA, Zee PC, Wagner LI. Factors influencing cognitive function, sleep, and quality of life in individuals with systemic lupus erythematosus: A review of the literature. Clin Neuropsychol. 2004 ; 18: 132-147
46. Thumboo J, Strand V. Health-related quality of life in patients with systemic lupus erythematosus: An update. Ann Acad Med Singapore. 2007 ; 36: 115-122
47. Rothman M, Burke L, Erickson P, Leidy NK, Patrick DL, Petrie D. Use of existing patient-reported outcome (PRO) instruments and their modification: The ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report. Value Health. 2009 ; 12: 1075-1083
48. Joffe H, Yardley L Research methods for clinical and health psychology. Marks D Yardley L, ed. London: Sage ; 2004: 56-68.
49. Morse JM. The significance of saturation. Qual Health Res. 1995 ; 5: 147-149
50. Kerr C, Nixon A, Wild D. Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. Expert Rev Pharmacoecon Outcomes Res. 2010 ; 10: 269-281
51. Hewlett S, Chalder T, Choy E, et al. Fatigue in rheumatoid arthritis: Time for a conceptual model. Rheumatology (Oxford). 2011 ; 50: 1004-1006
52. Repping-Wuts H, Uitterhoeve R, van Riel P, van Achterberg T. Fatigue as experienced by patients with rheumatoid arthritis (RA): A qualitative study. Int J Nurs Stud. 2008 ; 45: 995-1002
53. Nikolaus S, Bode C, Taal E, van de Laar MA. New insights into the experience of fatigue among patients with rheumatoid arthritis: A qualitative study. Ann Rheum Dis. 2010 ; 69: 895-897
54. Food and Drug Administration: Guidance for Industry. Patient-reported outcome measures: Use in medical product development to support labeling claims. December 2009. http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf (accessed 25.10.2013).
55. Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity - establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 1 - eliciting concepts for a new PRO instrument. Value Health. 2011 ; 14: 967-977
56. Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity - establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: Part 2 - assessing respondent understanding. Value Health. 2011 ; 14: 978-988
57. Patrick DL, Burke LB, Powers JH, et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007 ; 10: S125 - S137